Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-6,200
Closed -$251K 4938
2016
Q4
$251K Sell
6,200
-37,300
-86% -$1.47M ﹤0.01% 3150
2016
Q3
$1.66M Sell
43,500
-28,800
-40% -$1.16M 0.01% 1400
2016
Q2
$3.03M Buy
72,300
+53,700
+289% +$2.2M 0.02% 943
2016
Q1
$747K Buy
18,600
+300
+2% +$12.1K 0.01% 1939
2015
Q4
$780K Sell
18,300
-2,800
-13% -$129K 0.01% 2170
2015
Q3
$1M Buy
21,100
+20,700
+5,175% +$1.05M 0.01% 2187
2015
Q2
$20K Buy
+400
New +$20.3K ﹤0.01% 4792
2014
Q3
Sell
-8,100
Closed -$431K 5121
2014
Q2
$431K Sell
8,100
-95,300
-92% -$5.06M ﹤0.01% 2447
2014
Q1
$5.41M Buy
103,400
+70,000
+210% +$3.54M 0.05% 584
2013
Q4
$1.79M Sell
33,400
-73,600
-69% -$3.8M 0.01% 1530
2013
Q3
$2.71M Buy
107,000
+58,900
+122% +$3M 0.02% 1279
2013
Q2
$2.48K Buy
+48,100
New +$2.56M 0.01% 1325

Other funds holding SNY

PEAK6 Group's SNY Position: Q2 2016 in Review

PEAK6 Group sold out of Sanofi (SNY) in Q2 2016, closing a stake of 5,357 shares — an estimated $220K sold.

PEAK6 Group first reported a position in SNY in Q2 2013 and held it in 8 quarters. The position peaked at $661K in Q1 2014. 449 funds tracked by Wall St. Rank hold SNY as of Q2 2016.

  • PEAK6 Group reported no remaining Sanofi position as of Q2 2016 after selling out during the quarter.
  • PEAK6 Group sold 5,357 Sanofi shares in Q2 2016, an estimated $220K.
  • PEAK6 Group first reported a position in Sanofi in Q2 2013 and held it in 8 quarters.
  • PEAK6 Group's Sanofi position peaked at $661K in Q1 2014.
  • 449 funds tracked by Wall St. Rank held Sanofi as of Q2 2016.

Based on PEAK6 Group's 13F filing for Q2 2016, filed 10 Aug 2016.